BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2899439)

  • 1. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
    Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ; Grant S; McLenachan J
    Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved left ventricular function during exercise: a comparison of celiprolol and atenolol.
    McLenachan J; Wilson J; Dargie H
    Am Heart J; 1988 Nov; 116(5 Pt 2):1435-6. PubMed ID: 2903655
    [No Abstract]   [Full Text] [Related]  

  • 7. A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol.
    Jackson NC; Lee PS; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S145-7. PubMed ID: 2427846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of carvedilol and atenolol for angina pectoris.
    Freedman SB; Jamal SM; Harris PJ; Kelly DT
    Am J Cardiol; 1987 Sep; 60(7):499-502. PubMed ID: 2888302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol in the treatment of angina pectoris.
    Erikssen J; Osvik K; Dedichen J
    Acta Med Scand; 1977; 201(6):579-84. PubMed ID: 17996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II.
    McLenachan JM; Grant S; Ford I; Henderson E; Dargie HJ
    Am Heart J; 1991 Feb; 121(2 Pt 2):691-6. PubMed ID: 1671188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
    Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
    Chambers J; Ong ML; Akhras F; Adam G; Jackson G
    Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol.
    Ray SG; McCann G; Henderson E; MacFarlane N; Christie J; Norrie J; Ford I; Grant S; Dargie HJ
    Eur Heart J; 1994 Nov; 15(11):1566-70. PubMed ID: 7835373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
    Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
    Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.